Medanta Lucknow to Lead Academic Deliberations at Haematocon 2025

The four-day academic event promises to be a landmark gathering for haematology professionals, bringing together over 100 national and international faculty members who will deliberate on recent advancements and future directions in Haematology, Bone Marrow Transplantation, and Cellular Therapy. The conference will feature plenary sessions, panel discussions, paper presentations, and interactive workshops, making it a comprehensive learning platform for clinicians, researchers, and students.

As part of Haematocon 2025, the Department of Haematology and Bone Marrow Transplant at Medanta Lucknow will organize two specialized pre-conference workshops one on CAR-T Cell Therapy and another on Stem Cell Enumeration & Cryopreservation. These sessions will provide participants with hands-on training and deeper insights into emerging therapeutic approaches that are reshaping modern cancer and blood disorder management.

Highlighting the significance of the event, Dr. Anshul Gupta, Director, Department of Haematology and Bone Marrow Transplant, Medanta Lucknow, said: “Haematocon 2025 represents a unique confluence of science, skill, and collaboration. As we move into an era of personalized and cellular therapy, this platform will help bridge the gap between research and real-world treatment. At Medanta Lucknow, we take pride in being among the few centres in Uttar Pradesh successfully performing both stem cell transplants and CAR-T cell therapies, offering new hope to patients battling complex haematological disorders.”

With a strong focus on innovation, education, and clinical excellence, Haematocon 2025 aims to shape the next chapter of India’s haematology landscape and reinforce Lucknow’s position as an emerging hub of advanced medical research.